KE3300A - Androstadine-17-carboxylic acids and their esters - Google Patents
Androstadine-17-carboxylic acids and their estersInfo
- Publication number
- KE3300A KE3300A KE3300A KE330083A KE3300A KE 3300 A KE3300 A KE 3300A KE 3300 A KE3300 A KE 3300A KE 330083 A KE330083 A KE 330083A KE 3300 A KE3300 A KE 3300A
- Authority
- KE
- Kenya
- Prior art keywords
- androstadine
- esters
- carboxylic acids
- carboxylic
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH225376A CH628355A5 (de) | 1976-02-24 | 1976-02-24 | Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze. |
Publications (1)
Publication Number | Publication Date |
---|---|
KE3300A true KE3300A (en) | 1983-08-05 |
Family
ID=4229445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KE3300A KE3300A (en) | 1976-02-24 | 1983-06-23 | Androstadine-17-carboxylic acids and their esters |
Country Status (26)
Country | Link |
---|---|
US (1) | US4285937A (de) |
JP (1) | JPS52102264A (de) |
AT (1) | AT361141B (de) |
AU (1) | AU513559B2 (de) |
BE (1) | BE851725A (de) |
CA (1) | CA1084483A (de) |
CH (4) | CH628355A5 (de) |
CY (1) | CY1198A (de) |
DD (1) | DD145918A5 (de) |
DE (1) | DE2707336A1 (de) |
DK (1) | DK153493C (de) |
ES (5) | ES456134A1 (de) |
FR (2) | FR2342302A1 (de) |
GB (1) | GB1578243A (de) |
HK (1) | HK57483A (de) |
HU (1) | HU176762B (de) |
IE (1) | IE45023B1 (de) |
IL (2) | IL51519A (de) |
KE (1) | KE3300A (de) |
MX (1) | MX9203366A (de) |
MY (1) | MY8500017A (de) |
NL (1) | NL7701886A (de) |
NZ (1) | NZ183418A (de) |
SE (1) | SE436572B (de) |
SG (1) | SG37383G (de) |
ZA (1) | ZA771087B (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4188385A (en) * | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
PT69411A (en) * | 1978-04-05 | 1979-04-01 | Syntex Inc | 4-halo etianic acids and derivatives thereof |
US4198403A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | 17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes |
DE3024008C2 (de) * | 1980-06-24 | 1982-04-15 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 17α-Hydroxy-etiocarbonsäuren |
US4607028A (en) * | 1983-08-18 | 1986-08-19 | Ciba-Geigy Corporation | Novel carboxylic acid esters |
SE8306370D0 (sv) * | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
IL78144A0 (en) * | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
SE8501693D0 (sv) * | 1985-04-04 | 1985-04-04 | Draco Ab | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
WO1990015816A1 (en) * | 1989-06-16 | 1990-12-27 | The Upjohn Company | Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
US6596260B1 (en) | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
US5646136A (en) * | 1994-01-04 | 1997-07-08 | Duke University | Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
US5981517A (en) * | 1996-05-09 | 1999-11-09 | Soft Drugs, Inc. | Androstene derivatives |
GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
AR032471A1 (es) * | 2000-08-05 | 2003-11-12 | Glaxo Group Ltd | Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6858593B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
CA2445839A1 (en) * | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
GB2389530B (en) * | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
KR20060032596A (ko) * | 2003-06-19 | 2006-04-17 | 니콜라스 에스. 보도 | 국부 또는 다른 국소 투여를 위한 연성 항염증스테로이드의 활성 및/또는 작용기간의 증진 |
DE602004008083T2 (de) * | 2003-06-19 | 2008-04-24 | Nicholas S. Gainsville Bodor | Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
AU2006305620A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US7687484B2 (en) * | 2006-05-25 | 2010-03-30 | Bodor Nicholas S | Transporter enhanced corticosteroid activity |
US7691811B2 (en) * | 2006-05-25 | 2010-04-06 | Bodor Nicholas S | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
US8227027B2 (en) | 2007-12-07 | 2012-07-24 | Presspart Gmbh & Co. Kg | Method for applying a polymer coating to an internal surface of a container |
EP2111861A1 (de) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Zusammensetzungen von Phosphodiesterase-IV-Hemmern |
US8835410B2 (en) | 2011-05-10 | 2014-09-16 | Bodor Laboratories, Inc. | Treatment of eyelid dermatitis |
CN111100176A (zh) * | 2019-12-20 | 2020-05-05 | 重庆华邦胜凯制药有限公司 | 一种化合物的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636010A (en) * | 1968-12-23 | 1972-01-18 | Ciba Geigy Corp | Esters of steroid-17-carboxylic acids |
GB1384372A (en) * | 1971-01-20 | 1975-02-19 | Glaxo Lab Ltd | Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids |
GB1438940A (en) * | 1972-07-19 | 1976-06-09 | Glaxo Lab Ltd | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids |
GB1514476A (en) * | 1974-08-30 | 1978-06-14 | Glaxo Lab Ltd | Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates |
US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
-
1976
- 1976-02-24 CH CH225376A patent/CH628355A5/de not_active IP Right Cessation
-
1977
- 1977-02-18 CY CY1198A patent/CY1198A/xx unknown
- 1977-02-18 GB GB6955/77A patent/GB1578243A/en not_active Expired
- 1977-02-19 DE DE19772707336 patent/DE2707336A1/de active Granted
- 1977-02-22 FR FR7705053A patent/FR2342302A1/fr active Granted
- 1977-02-22 NL NL7701886A patent/NL7701886A/xx unknown
- 1977-02-22 CA CA272,291A patent/CA1084483A/en not_active Expired
- 1977-02-22 DD DD77197502A patent/DD145918A5/de unknown
- 1977-02-22 IL IL51519A patent/IL51519A/xx unknown
- 1977-02-22 ES ES456134A patent/ES456134A1/es not_active Expired
- 1977-02-23 IE IE382/77A patent/IE45023B1/en not_active IP Right Cessation
- 1977-02-23 HU HU77CI1720A patent/HU176762B/hu unknown
- 1977-02-23 BE BE175169A patent/BE851725A/xx not_active IP Right Cessation
- 1977-02-23 NZ NZ183418A patent/NZ183418A/xx unknown
- 1977-02-23 DK DK079077A patent/DK153493C/da not_active IP Right Cessation
- 1977-02-23 ZA ZA00771087A patent/ZA771087B/xx unknown
- 1977-02-23 AT AT119477A patent/AT361141B/de not_active IP Right Cessation
- 1977-02-23 AU AU22572/77A patent/AU513559B2/en not_active Expired
- 1977-02-23 SE SE7701999A patent/SE436572B/xx not_active IP Right Cessation
- 1977-02-24 JP JP1874377A patent/JPS52102264A/ja active Granted
-
1978
- 1978-01-27 FR FR7802324A patent/FR2369297A1/fr active Granted
- 1978-03-01 ES ES467430A patent/ES467430A1/es not_active Expired
- 1978-03-01 ES ES467432A patent/ES467432A1/es not_active Expired
- 1978-03-01 ES ES467433A patent/ES467433A1/es not_active Expired
- 1978-03-01 ES ES467434A patent/ES467434A1/es not_active Expired
-
1979
- 1979-10-30 US US06/089,677 patent/US4285937A/en not_active Expired - Lifetime
-
1980
- 1980-11-19 IL IL61512A patent/IL61512A0/xx unknown
-
1981
- 1981-06-11 CH CH383381A patent/CH628641A5/de not_active IP Right Cessation
- 1981-06-11 CH CH383181A patent/CH629824A5/de not_active IP Right Cessation
- 1981-06-11 CH CH383281A patent/CH628356A5/de not_active IP Right Cessation
-
1983
- 1983-06-23 KE KE3300A patent/KE3300A/xx unknown
- 1983-06-27 SG SG373/83A patent/SG37383G/en unknown
- 1983-11-17 HK HK574/83A patent/HK57483A/xx unknown
-
1985
- 1985-12-30 MY MY17/85A patent/MY8500017A/xx unknown
-
1992
- 1992-06-25 MX MX9203366A patent/MX9203366A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KE3300A (en) | Androstadine-17-carboxylic acids and their esters | |
ZA77564B (en) | Carboxyalkylacylamino acids | |
IL51705A (en) | Acetohydroxamic acids and their preparation | |
GB1542938A (en) | Aminophosphonous acids and processes for their preparation | |
GR63666B (en) | Trans-hexahydro-pyrido-indole-2-alkanols,-alkanones,-alkanonitriles-alkanoic acids 8 esters | |
ZA773055B (en) | 12-azaprostanoic acids | |
JPS5291814A (en) | Polyfluoroalkylthioalcohol and ester * their preparation and use | |
IL53692A (en) | 17-hydroxy-pregn-4-ene-21-carboxylic acids and the corresponding lactones and their preparation | |
IL54200A0 (en) | The preparation of dihalogenovinylcyclopropanecarboxylic acids and their esters | |
GB2040287B (en) | 6-alkyl-1,2-dihydro-2-oxonicotinic acids and esters | |
PH13826A (en) | 8-halo-dibenzofuras-3-acetic acids and certain esters thereof | |
AU2423177A (en) | Esters | |
AU2985577A (en) | N-chloroacetyl-n-phenyl-alanine esters | |
AU2266077A (en) | 15, 16-dioxy prostenoic acids and esters | |
AU510882B2 (en) | Esters of naphthyl allohols | |
JPS5470222A (en) | Nncarboxyalkaneephosphoric acids and manufacture | |
NZ185901A (en) | 1-aziridine-carboxylic acid esters and their preparation | |
AU3462178A (en) | Prostenoic acids and esters | |
PT67412B (en) | Esters | |
JPS5470243A (en) | Esters and manufacture | |
IL52868A0 (en) | The preparation of esters of thiocarbamic acids | |
GR63657B (en) | Trans-octahydro-pyrido-pyrrolo-benzazepine-3-alkanols,-alkanonitriles,-alkanoic acids and esters | |
AU507077B2 (en) | Arykoxyalklaminobenzoil Acids and Esters | |
IE44932L (en) | 2-arylalkanoate acids and esters. | |
IL50155A (en) | 6,11 dihydro-11-oxodibenz oxepinalkynoic acids and esters thereof |